Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy

BackgroundImmune checkpoint inhibitors (ICIs) are used to treat locally-advanced and metastatic lung cancer, which can lead to severe immunogenic-related cardiotoxicities. We assessed the risk of cardiotoxicity in ICI-treated lung cancer patients with or without cardiac radiation from thoracic radio...

Full description

Bibliographic Details
Main Authors: Christine Son, Melissa Y. Y. Moey, Paul R. Walker, Abdul R. Naqash, Matthew Sean Peach, Andrew W. Ju
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitors (ICI)
immunotherapy
radiotherapy
cardiotoxicity
cardiac radiation dose
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1025455/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1025455/full

Similar Items